Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2005
10/11/2005USRE38824 biologically pure, isolated human B lymphotropic virus, molecular clones, nucleic acids, distinctive antigenic proteins and a method for detecting antibodies to the new virus
10/11/2005US6953875 Animal model for use in the treatment and diagnosis of cancers
10/11/2005US6953874 Transgenic animals having a modified glycoprotein V gene
10/11/2005US6953848 Pepper gene promoters; drives gene expression in transgenic plants
10/11/2005US6953847 Fas antigen derivative
10/11/2005US6953844 Isolation of neurotrophins from a mixture containing neurotrophin variants using hydrophobic interaction chromatography
10/11/2005US6953843 Antibodies and fragments thereof to MDL-1 protein
10/11/2005US6953842 Antibodies to heregulin 2
10/11/2005US6953841 Polypeptides having at least about 80% amino acid sequence identity to a PRO polypeptide lacking its associated signal peptide
10/11/2005US6953840 Methods of using non-human animal Apolipoprotein A-I protein
10/11/2005US6953839 recombinant triple helical proteins; collagen-like peptides
10/11/2005US6953838 Urocortin-III and uses thereof
10/11/2005US6953837 Factor VIII/vWF complexes and compositions
10/11/2005US6953836 PRO844 polypeptides
10/11/2005US6953835 Coleopteran toxin proteins of bacillus thuringiensis
10/11/2005US6953834 Transcription factors related to TFIIA
10/11/2005US6953794 Monitoring treatment for nervous system didorders; obtain cell sample containing tau protein, incubate with modulator, monitor tau binding, adjustment in tau binding indicates modulators
10/11/2005US6953779 Administering oligopeptide
10/11/2005US6953778 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
10/11/2005US6953691 A vector codes domain, antibodies, for modulating NF kappa B protein transcriptional activity, antiapoptosis
10/11/2005US6953688 Vector for screening for modulators of IgE synthesis, secretion and switch rearrangement
10/11/2005US6953683 Compositions and methods of inhibiting bacterial spore germination
10/11/2005US6953682 Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
10/11/2005US6953680 Mitofusins, Fzo Homologs and functional derivatives thereof
10/11/2005US6953674 Inhibitors of human plasmin derived from the kunitz domains
10/11/2005US6953673 Histamine H2 receptor and uses
10/11/2005US6953672 Yeast cell model for monitoring and detecting modulators of serine-threonine kinase (CDC7) activity; antiproliferative agents; enzyme inhibitors
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953668 Prostate-specific membrane antigen
10/11/2005US6953667 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
10/11/2005US6953662 Follistatin-3
10/11/2005US6953657 Caspase recruitment domain (CARD); for diagnosis, screening, and treatment of apoptosis via genetic expression
10/11/2005US6953656 Direct, externally imposed control of polypeptides
10/11/2005US6953581 Porcine circovirus and parvovirus vaccine
10/11/2005US6953573 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
10/11/2005US6953550 Affinity binding-based system for detecting particulates in a fluid
10/11/2005US6953211 Anti-panic opening system for doors
10/11/2005CA2333875C Redox reversible bipyridyl osmium complex conjugates
10/11/2005CA2333732C Redox reversible imidazole-osmium complex conjugates
10/11/2005CA2196410C Control of plant gene expression
10/11/2005CA2087272C Cd53 cell surface antigen and use thereof
10/09/2005CA2501624A1 Cloning and expression of gonadotropin-releasing hormone (gnrh) receptors
10/06/2005WO2005093428A2 Chemokine ccl18 as a biomarker
10/06/2005WO2005093427A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 50 (gpr50)
10/06/2005WO2005093425A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 58 (gpr58)
10/06/2005WO2005093086A1 Method for screening agents modulating a lkb$g(a) protein ubiquitination and means for carrying out said method
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093080A2 Nitrile hydratase of rhodococcus
10/06/2005WO2005093077A1 Plants having improved growth characteristics and method for making the same
10/06/2005WO2005093075A1 Peptide-based method for monitoring gene expression in a host cell
10/06/2005WO2005093074A1 Gas1 universal leader
10/06/2005WO2005093070A1 Recombinant herpesvirus and utilization of the same
10/06/2005WO2005093069A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093062A1 Genetic markers usable in breeding beer barley and utilization of the same
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005093054A1 Modified phytochrome
10/06/2005WO2005093040A1 Eukaryotic cells expressing phycocyanin
10/06/2005WO2005092928A1 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
10/06/2005WO2005092924A2 Rab9a, rab11a, and modulators thereof related to infectious disease
10/06/2005WO2005092923A2 Cytonectin and gene inhibitors thereof
10/06/2005WO2005092922A2 Antigen of the pm-2 antibody and use thereof
10/06/2005WO2005092921A2 Placental growth factor splice variants and their uses
10/06/2005WO2005092920A1 Mussel bioadhesive
10/06/2005WO2005092919A1 Flowering time-controlling gene cog2 isolated from arabidopsis thaliana
10/06/2005WO2005092918A2 Targeting polypeptide
10/06/2005WO2005092917A1 Library of toxin mutants, and methods of using same
10/06/2005WO2005092914A1 Process for promoting proper folding of human serum albumin using a human serum albumin ligand
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092381A1 Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
10/06/2005WO2005092379A2 Materials and methods for treatment of cancer
10/06/2005WO2005092362A2 Pharmaceutical combined preparation containing a therapeutic protein
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005092016A2 Compositions and methods for controlling insects related to the octopamine receptor
10/06/2005WO2005091956A2 In vitro test system for predicting patient tolerability of therapeutic agents
10/06/2005WO2005091944A2 Glycol linked fgf-21 compounds
10/06/2005WO2005091925A2 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
10/06/2005WO2005091856A2 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
10/06/2005WO2005091777A2 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides
10/06/2005WO2005091753A2 Flexible vaccine assembly and vaccine delivery platform
10/06/2005WO2005091751A2 Novel gene associated with type 1 diabetes and methods of use
10/06/2005WO2005080939A3 Method and device for detecting feline immunodeficiency virus
10/06/2005WO2005077977A3 Carcinoembryonic antigen fusions proteins and uses thereof
10/06/2005WO2005075646A8 Peptide originating in stress-induced antiapoptosis molecule (iex-1)
10/06/2005WO2005072893A8 Functionalized colloidal metal compositions and methods
10/06/2005WO2005070136A3 Up-regulation of bone morphogenetic protein (bmp) gene expression in bone cells by electromagnetic signals
10/06/2005WO2005070041A3 Modulating vaccine against hiv nef protein-induced lymphocyte depletion
10/06/2005WO2005063997A3 Maize metallothionein promoter
10/06/2005WO2005060350A3 Diastereomeric peptides useful as inhibitors of membrane protein assembly
10/06/2005WO2005056595A3 T cell receptor specific for wilms tumor antigen
10/06/2005WO2005054445A8 A method for isolating a self-renewing, multipotent slow-cycling cell
10/06/2005WO2005046720A3 Diagnosis, prognosis and treatment of pulmonary diseases using foxa2
10/06/2005WO2005042566A3 Antiangiogenicpeptides for treating or preventing endometriosis
10/06/2005WO2005042559A3 Capture and release based isotope tagged peptides and methods for using the same
10/06/2005WO2005028496A3 Vaccine for treatment and prevention of herpes simplex virus infection
10/06/2005WO2005026388A3 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
10/06/2005WO2005023850A3 Method for producing inosine and 5'-inosinic acid by fermentation using bacterium belonging to the genus escherichia
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 2916